UnitedHealthcare sued The Guardian on Wednesday for defamation, claiming the British daily ran information it knew to be ...

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

UnitedHealth (UNH) files a defamation lawsuit against The Guardian over its recent report on alleged kickbacks paid by the ...

Six weeks before UnitedHealthcare CEO Brian Thompson was gunned down outside a Manhattan hotel last December, Luigi Mangione ...

UnitedHealth Group (NYSE: UNH) stock has been in a free fall due to a flurry of bad news. Due to the sharp price decline, the ...

UnitedHealthcare and Optum's struggles with an evolving Medicare Advantage market have investors questioning if valued-based ...

The nation’s two largest Medicare Advantage (MA) insurers say they support reforming the federal program to rein in certain ...

Stephen Hemsley previously served as CEO from 2006 through 2017 and has chaired the UnitedHealth Group board since 2017.

UnitedHealth Group prepared talking points for its shareholder meeting this week. The company published them Wednesday after ...

This year, however, has raised significant questions about just how safe the stock really is. Since January, UnitedHealth ...

UnitedHealth Group (UNH) concluded the recent trading session at $300.38, signifying a -0.28% move from its prior day's close.

US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper ...